| Univariate analysis | Multivariate analysis | ||
---|---|---|---|---|
 | HR (95% CI) | p-value | HR (95% CI) | p-value |
Osteoporotic drug usage status | ||||
 Without osteoporotic drug | Reference group | – | Reference group | – |
 MPR < 80% | 0.91 (0.818–1.011) | 0.0804 | 0.835 (0.748–0.932) | 0.0012 |
 MPR ≥ 80% | 0.401 (0.32–0.503) | <.0001 | 0.406 (0.322–0.511) | <.0001 |
Age | 1.062 (1.054–1.07) | <.0001 | 1.064 (1.055–1.072) | <.0001 |
Gender | ||||
 Male | Reference group |  | Reference group |  |
 Female | 0.746 (0.663–0.839) | <.0001 | 0.776 (0.684–0.88) | <.0001 |
Location | ||||
 North | Reference group |  | Reference group |  |
 Middle | 1.163 (1.025–1.321) | 0.0192 | 1.066 (0.919–1.236) | 0.4006 |
 Southern | 0.979 (0.861–1.114) | 0.7523 | 1.067 (0.926–1.23) | 0.367 |
 East | 1.169 (0.899–1.522) | 0.2442 | 1.047 (0.778–1.408) | 0.7639 |
Urbanization level | ||||
 Metropolitan areas | Reference group |  | Reference group |  |
 Satellite cities or towns | 1.146 (0.991–1.326) | 0.0657 | 1.163 (1–1.352) | 0.0498 |
 Rural areas | 1.202 (1.067–1.355) | 0.0026 | 1.204 (1.05–1.38) | 0.0076 |
Charlson comorbidity index | ||||
 0 | Reference group |  | Reference group |  |
 1 | 1.356 (1.134–1.622) | 0.0009 | 1.266 (1.048–1.529) | 0.0146 |
  ≥ 2 | 2.349 (2.018–2.733) | <.0001 | 1.727 (1.429–2.086) | <.0001 |
Comorbidity | ||||
 Diabetes | 1.206 (1.084–1.342) | 0.0006 | 1.242 (1.094–1.409) | 0.0008 |
 Hypertension | 1.008 (0.908–1.117) | 0.8874 | 0.898 (0.803–1.004) | 0.0591 |
 Cerebrovascular disease | 1.308 (1.172–1.46) | <.0001 | 1.063 (0.941–1.2) | 0.3256 |
 Heart disease | 1.246 (1.113–1.395) | 0.0001 | 1 (0.886–1.128) | 0.9996 |
 Cancer | 3.621 (2.812–4.662) | <.0001 | 2.521 (1.907–3.334) | <.0001 |
 Chronic liver disease | 1.22 (1.001–1.486) | 0.0485 | 1.194 (0.968–1.471) | 0.0978 |
 Chronic obstructive pulmonary disease | 1.759 (1.568–1.975) | <.0001 | 1.311 (1.151–1.493) | <.0001 |
 Chronic kidney disease | 1.891 (1.627–2.198) | <.0001 | 1.787 (1.518–2.104) | <.0001 |
 Hyperlipidemia | 0.658 (0.556–0.778) | <.0001 | 0.629 (0.524–0.755) | <.0001 |
Type of hip fracture | ||||
 Neck | Reference group |  | Reference group |  |
 Cervical | 1.124 (0.944–1.339) | 0.1896 | 1.098 (0.921–1.31) | 0.2979 |
 Trochanteric | 1.163 (1.041–1.3) | 0.0075 | 1.04 (0.929–1.164) | 0.5001 |
Prescribed by medical specialty | ||||
 Orthopedics | Reference group |  | Reference group |  |
 Non-orthopedics | 1.053 (0.948–1.169) | 0.3387 | 0.96 (0.861–1.071) | 0.4624 |